Insparya Group: The greatest experts in alopecia and follicular units

Alopecia is a disease characterised by severe hair loss. It can significantly impact self-esteem, raise stress levels, and even cause psychopathological disorders in individuals who are affected. The most common form of this disease is androgenic alopecia, which affects about half of the male population before the age of 50 and half of the female population throughout their lifetime. 

To date, drug treatments are limited to the drugs Minoxidil and Finasteride, approved by the FDA. Although these drugs are effective for some patients, they have significant side effects. Up until now, the most effective and common treatment for alopecia is hair transplant. Insparya is an expert in this field, thanks to its more than 14 years of experience and 50,000 intervened patients. However, hair transplantation is not a solution for all patients, as it is limited by the number of hair grafts in the donor region. Therefore, there is high demand for more effective therapeutic solutions for androgenic alopecia.

In this context, the main objective of Insparya Hair Science is to develop hair regeneration and rejuvenation strategies based on interdisciplinary knowledge and multi methodological approaches.